Cancer specific antibody and cell surface proteins

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8697075
APP PUB NO 20120128723A1
SERIAL NO

13297783

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides the amino acid and nucleic acid sequences of heavy chain and light chain complementarity determining regions of a cancer specific antibody. In addition, the invention provides cancer specific antibodies and immunoconjugates comprising the cancer specific antibody attached to a toxin or label, and methods and uses thereof. The invention also relates to diagnostic methods and kits using the cancer specific antibodies of the invention. Further, the invention provides a novel cancer-associated antigen and its uses thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VIVENTIA BIO INC147 HAMELIN STREET WINNIPEG MB R3T 3Z1

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chahal, Francina C Winnipeg, CA 14 62
Cizeau, Jeannick Winnipeg, CA 22 93
Entwistle, Joycelyn Winnipeg, CA 12 48
Glover, Nicholas Ronald Oakville, CA 16 74
MacDonald, Glen Christopher Winnipeg, CA 10 39

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 15, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00